MedTrace Logo

The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.

NCT07239219 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-11-20

No results posted yet for this study

Summary

Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.

Conditions

Interventions

OTHER

0.05% Chlorhexidine Gluconate

0.05% CHG is instilled into the bladder prior to trial of void.

OTHER

Normal Saline

Bladder is back filled with normal saline.

Sponsors & Collaborators

  • Irrimax Corporation

    collaborator INDUSTRY

  • Ohio State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2028-01-01
Completion
2028-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07239219 on ClinicalTrials.gov